Dr. Fabrizio Clementi

Fabrizio Clementi, MD, PhD, is an Interventional Cardiologist consultant of Cardiovascular Center.

Major Area of interest are Coronary Artery disease, Heart Failure, Valve disease.

He has more than 20 years of experience as Interventional Cardiologist.

Areas of Interest

Coronary and Structural heart intervention:

• Chronic Total Occlusions
• TAVR
• Mitraclip
• ASD/VSD
• Carotid intervention
• Pudenda artery intervention
• Bariatric embolization for treatment of Obesity

Education

• He graduated in Medicine as first ranking first of his course in 1996 at Catholic University of Rome, Italy.
• He had his fellowship in cardiology for 4 years in Cardiology Department lead by Professor Attilio Maseri at University
• Hospital Policlinico Gemelli in Rome Italy.
• He got a PhD degree at University of Rome Tor Vergata, Italy in Cardiovascular Physiopathology in 2005

Working Experience

• January 2018 to date, Sheikh Khalifa Speciality Hospital, Cardiovascular Department, Consultant Interventional Cardiologist., Head of Cardiology since February 2019
• April 2005 to January 2018, University Hospital of Rome Tor Vergata, Department of Medicine, Division of Cardiology and Interventional cardiology, Senior Staff Specialist in Interventional Cardiology
• May 2003 to March 2005, University Hospital of Rome Tor Vergata, Department of Medicine, Division of Cardiology and Interventional cardiology, Senior staff Specialist for Intensive Coronary Unit (ICU)
• April 2001 to April 2003, University Hospital of Rome Tor Vergata, Department of Medicine, Division of Cardiology and Interventional cardiology, Staff Specialist of non-invasive out of hospital Cardiology Unit
• December 2000 to April 2001, Private Clinic Quisisana, Consultant cardiologist for pre and post cardiac surgery

Teaching Experience

• From September 2005 to February 2018, University of Rome Tor Vergata, Faculty of Medicine, Contract Professor of the Advance Training Board in Cardiology
• February 2007, Joint Interventional Meeting- Door to Balloon virtual emergency at JIM
• February 2008, Joint Interventional Meeting- Door to Balloon virtual emergency at JIM
• May-June 2008 -February 2009, University of Rome Tor Vergata – Clinical path of patients with Intra Aortic Balloon Counterpulsation
• January-March 2009, University of Rome Tor Vergata – Clinical Research: a revised approach
• April 2011, University of Rome Tor Vergata – Practical training in manual technique of Coronary Interventional Lab
• Faculty, Oral presenting author, Invited speaker and Chair in several national and international congresses

Academic Activities

Publications and patents:

• Mango R, Clementi F, Borgiani P, Forleo GB, Federici M, Contino G, Giardina E, Garza L, Fahdi IE, Lauro R, Mehta JL, Novelli G, Romeo F. Association of single nucleotide polymorphisms in the xidised LDL receptor 1 (OLR1) gene in patients with acute myocardial infarction. J Med Genet. 2003 Dec;40(12):933-6.
• Muscoli C, Sacco I, Alecce W, Palma E, Nisticò R, Costa N, Clementi F, Rotiroti D, Romeo F, Salvemini D, Mehta JL, Mollace V.The protective effect of superoxide dismutase mimetic M40401 on balloon injury-related neointima formation: role of the lectin-like oxidized low-density lipoprotein receptor-1.J Pharmacol Exp Ther. 2004 Oct;311(1):44-50.
• Mango R, Biocca S, del Vecchio F, Clementi F, Sangiuolo F, Amati F, Filareto A, Grelli S, Spitalieri P, Filesi I, Favalli C, Lauro R, Mehta JL, Romeo F, Novelli G.In vivo and in vitro studies support that a new splicing isoform of OLR1 gene is protective against acute myocardial infarction. Circ Res. 2005 Jul 22;97(2):152-8.
• Romeo F, Leo R, Clementi F, Razzini C, Borzi M, Martuscelli E, Pizzuto F, Chiricolo G, Mehta JL. Multislice computed tomography in an asymptomatic high-risk population. Am J Cardiol. 2007 Feb 1;99(3):325-8.
• Cola C, Clementi E, Biondi-Zoccai G, Sangiorgi G. From carotid plaque biology to serologic markers of vulnerability to predict the risk of cerebrovascular events. Acta Chir Belg. 2007 Mar-Apr;107(2):129-42. Review.
• Sangiorgi G, Melzi G, Agostoni P, Cola C, Clementi F, Romitelli P, Virmani R, Colombo A. Engineering aspects of stents design and their translation into clinical practice. Ann Ist Super Sanita. 2007;43(1):89-100. Review.
• Sangiorgi GM, Clementi F, Cola C, Biondi-Zoccai G. Plaque vulnerability and related coronary event prediction by intravascular ultrasound with virtual histology: "it's a long way to tipperary"? Catheter Cardiovasc Interv. 2007 Aug 1;70(2):203-10. Review.
• Forleo GB, Tondo C, De Luca L, Dello Russo A, Casella M, De Sanctis V, Clementi F, Fagundes RL, Leo R, Romeo F, Mantica M. Gender-related differences in catheter ablation of atrial fibrillation. Europace. 2007 Aug;9(8):613-20.
• Martuscelli E, Clementi F, Gallagher MM, D'Eliseo A, Chiricolo G, Nigri A, Marino B, Romeo F; on behalf of CABRI trialists. Revascularization strategy in patients with multivessel disease and a major vessel chronically occluded; data from the CABRI trial. Eur J Cardiothorac Surg. 2008 Jan;33(1):4-8.
• Rizza S., Clementi F., Porzio O., Cardellini M., Savo A., Serino M., Chiricolo G., Romeo F., Lauro R., Federici M. Adiponectin isoforms are not associated to severity of coronary atherosclerosis but to undiagnosed diabetes in patients affected by stable CAD. Nutrition, Metabolism & Cardiovascular Diseases. 2008 May 7.
• Giuseppe G.L. Biondi-Zoccai, Marco Valgimigli, Imad Sheiban, Massimo Margheri, Antonio Marzocchi, Francesco Prati, Pasquale Lisanti, Corrado Lettieri, Bernhard Reimersi, Carlo Briguori, Amerigo Stabile, Fabrizio Clementi, Francesco Romeo, Antonio Colombo, and Giuseppe Sangiorgi.
• A randomized trial comparing eptifibatide vs. placebo in patients with diffuse coronary artery disease undergoing drug-eluting stent implantation: design of the INtegrilin plus STenting to Avoid myocardial Necrosis Trial. JCM 2008 Sep;9(9):957-62.
• Regression and shift in composition of coronary atherosclerotic plaques by pioglitazone: insight from an intravascular ultrasound analysis.Clementi F, Di Luozzo M, Mango R, Luciani G, Trivisonno A, Pizzuto F, Martuscelli E, Mehta JL, Romeo F.J Cardiovasc Med (Hagerstown). 2009 Mar;10(3):231-7.
• [Treatment of coronary bifurcation lesions].Romagnoli E, Clementi F, Biondi-Zoccai GG, Sangiorgi GM. G Ital Cardiol (Rome). 2008 Oct;9(10):690-705. Review
• Paclitaxel eluting balloon: from bench to bedside.Marzullo R, Aprile A, Clementi F, Stella P, Modena MG, Sangiorgi GM. Minerva Cardioangiol. 2009 Oct;57(5):597-609. Review.
• Incidence and predictors of coronary stent thrombosis: evidence from an international collaborative meta-analysis including 30 studies, 221,066 patients, and 4276 thromboses. D'Ascenzo F, Bollati M, Clementi F, Castagno D, Lagerqvist B, de la Torre Hernandez JM, ten Berg JM, Brodie BR, Urban P, Jensen LO, Sardi G, Waksman R, Lasala JM, Schulz S, Stone GW, Airoldi F, Colombo A, Lemesle G, Applegate RJ, Buonamici P, Kirtane AJ, Undas A, Sheiban I, Gaita F, Sangiorgi G, Modena MG, Frati G, Biondi-Zoccai G. Int J Cardiol. 2013 Jul 31;167(2):575-84